Malaysian Genomics Resource Total Liabilities
Malaysian Genomics Resource total liabilities. Based on the latest financial reports, Malaysian Genomics Resource (0155) has total liabilities worth RM3.09 Million MYR (≈ $776.05K USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Malaysian Genomics Resource defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Malaysian Genomics Resource (2015–2026)
Total liabilities of Malaysian Genomics Resource from 2015 to 2026. This chart illustrates how Malaysian Genomics Resource's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Malaysian Genomics Resource generate to measure how efficiently the company converts operating cash flow to free cash.
Malaysian Genomics Resource Competitors by Total Liabilities
The table below lists competitors of Malaysian Genomics Resource ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Medicon Hellas S.A.
AT:MEDIC
|
Greece | €14.85 Million |
|
iZafe Group AB Series B
ST:IZAFE-B
|
Sweden | Skr26.10 Million |
|
Medience Co. LTD
KQ:014100
|
Korea | ₩42.33 Billion |
|
OpTeam S.A.
WAR:OPM
|
Poland | zł25.66 Million |
|
Little Green Pharma Ltd
AU:LGP
|
Australia | AU$11.59 Million |
|
Spire Healthcare Group Plc
LSE:SPI
|
UK | GBX1.63 Billion |
|
Baillie Gifford US Growth Trust PLC
LSE:USA
|
UK | GBX39.47 Million |
|
Azio AI Holdings, Inc.
NASDAQ:AZIO
|
USA | $27.94 Million |
Liability Composition Analysis (2015–2026)
This chart breaks down Malaysian Genomics Resource's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 0155 current and non-current assets.
Liquidity & Leverage Metrics
Malaysian Genomics Resource Total Liabilities Ratios Explained
Malaysian Genomics Resource total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.74 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Malaysian Genomics Resource's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Malaysian Genomics Resource (2015–2026)
The table below shows the annual total liabilities of Malaysian Genomics Resource from 2015 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-06-30 | RM3.92 Million ≈ $985.33K |
-6.55% |
| 2025-06-30 | RM4.20 Million ≈ $1.05 Million |
+25.12% |
| 2024-06-30 | RM3.36 Million ≈ $842.77K |
-17.81% |
| 2023-06-30 | RM4.08 Million ≈ $1.03 Million |
-15.67% |
| 2022-06-30 | RM4.84 Million ≈ $1.22 Million |
-0.20% |
| 2021-06-30 | RM4.85 Million ≈ $1.22 Million |
+486.11% |
| 2020-06-30 | RM827.98K ≈ $207.88K |
-96.07% |
| 2019-06-30 | RM21.07 Million ≈ $5.29 Million |
+0.01% |
| 2018-06-30 | RM21.07 Million ≈ $5.29 Million |
+56.14% |
| 2017-06-30 | RM13.49 Million ≈ $3.39 Million |
+550.16% |
| 2016-06-30 | RM2.08 Million ≈ $521.09K |
-48.95% |
| 2015-06-30 | RM4.07 Million ≈ $1.02 Million |
-- |
About Malaysian Genomics Resource
Malaysian Genomics Resource Centre Berhad, together with its subsidiaries, provides genetics, genomics, immunotherapy, and biopharmaceutical services in Malaysia. The company offers genetic screening services that includes Dtect and Origene genetic testing solutions which provides individuals with insights into genetic predispositions related to health risks, wellness, and lifestyle traits. It al… Read more